BASSI, Cristian
 Distribuzione geografica
Continente #
NA - Nord America 2.077
EU - Europa 693
AS - Asia 383
AF - Africa 1
OC - Oceania 1
Totale 3.155
Nazione #
US - Stati Uniti d'America 2.076
IT - Italia 219
CN - Cina 205
PL - Polonia 184
TR - Turchia 77
GB - Regno Unito 64
DE - Germania 55
UA - Ucraina 54
SG - Singapore 53
SE - Svezia 52
BE - Belgio 22
ID - Indonesia 19
FI - Finlandia 18
VN - Vietnam 17
FR - Francia 7
CZ - Repubblica Ceca 5
HK - Hong Kong 5
IE - Irlanda 4
IR - Iran 3
AT - Austria 2
HU - Ungheria 2
IN - India 2
RO - Romania 2
AU - Australia 1
CA - Canada 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
KZ - Kazakistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.155
Città #
Fairfield 328
Woodbridge 267
Warsaw 184
Chandler 171
Ashburn 162
Ann Arbor 160
Houston 149
Seattle 131
Cambridge 108
Ferrara 105
Wilmington 104
Jacksonville 79
Beijing 69
New York 47
Izmir 42
Milan 33
Nanjing 33
Shanghai 33
Singapore 31
Princeton 29
San Diego 23
Brussels 22
Jakarta 19
Boardman 18
Addison 16
Bremen 16
Dong Ket 15
Los Angeles 11
Shenyang 10
Bologna 9
Falls Church 9
London 9
Mountain View 9
Nanchang 9
Redwood City 9
Washington 9
Tianjin 8
Hebei 7
Monte San Pietro 6
Brno 5
Changsha 5
Ferrara di Monte Baldo 5
Dublin 4
Hong Kong 4
Ningbo 4
Dearborn 3
Des Moines 3
Hangzhou 3
Helsinki 3
Jiaxing 3
Jinan 3
Kunming 3
Acton 2
Ardabil 2
Augusta 2
Bolzano 2
Celldömölk 2
Florence 2
Focsani 2
Hanoi 2
Lappeenranta 2
L’Aquila 2
Modena 2
Orange 2
Parma 2
Redmond 2
San Giorgio Di Piano 2
Stockholm 2
Vienna 2
Zhengzhou 2
Agna 1
Anzola Dell'emilia 1
Arcene 1
Basel 1
Berlin 1
Brescia 1
Brookline 1
Central District 1
Changchun 1
Chicago 1
Columbus 1
Edinburgh 1
Greenwich 1
Guangzhou 1
Hounslow 1
Hull 1
Islington 1
Lanzhou 1
Leawood 1
Monmouth Junction 1
Norwalk 1
Pavullo Nel Frignano 1
Prescot 1
Pune 1
San Jose 1
San Vincenzo 1
Santa Maria di Sala 1
Taizhou 1
Tallinn 1
Tewksbury 1
Totale 2.613
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
Absolute quantification of cell-free microRNAs in cancer patients 178
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 159
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 154
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 146
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 146
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 139
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 136
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 122
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 122
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 116
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 112
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 107
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 106
Interspecies gene name extrapolation - A new approach 100
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 94
null 89
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 78
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 75
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 73
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 67
Defining the oral microbiome by whole-genome sequencing and resistome analysis: The complexity of the healthy picture 61
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 57
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 43
Detection of disease-causing mutations in prostate cancer by NGS sequencing 33
Novel Virus Identification through Metagenomics: A Systematic Review 25
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 19
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 15
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 14
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 11
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 11
Totale 3.260
Categoria #
all - tutte 15.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020581 0 0 30 92 58 72 69 65 67 61 29 38
2020/2021721 41 69 48 63 38 64 40 54 29 157 80 38
2021/2022359 15 22 31 12 21 19 38 17 12 31 41 100
2022/2023398 35 40 24 53 54 61 39 24 35 6 17 10
2023/2024286 17 25 17 8 35 76 13 12 4 8 6 65
2024/202553 27 26 0 0 0 0 0 0 0 0 0 0
Totale 3.260